Clinical and Inflammatory Benefits of Nebulized Furosemide with Salbutamol–ipratropium in COPD Exacerbations: A Randomized Controlled Trial
- DOI
- 10.18502/ijaai.v25is11.22488
- Published
- 2026-09-02
- Container
- Iranian Journal of Allergy, Asthma and Immunology
- Publisher
- Knowledge E DMCC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.18502/ijaai.v25is11.22488,
title = {Clinical and Inflammatory Benefits of Nebulized Furosemide with Salbutamol–ipratropium in COPD Exacerbations: A Randomized Controlled Trial},
author = {Mahdi Behi and Babak Gholamine and Mohammad Reza Masjedi and Alireza Eslaminejad and Esmaeil Idani and Mohsen Sadeghi and Akram Qanavati and Sayed Mehran Marashian and Esmaeil Mortaz and Atefeh Abedini and Mihan Pourabdollah and Bita Pakshad and Saeid Mahmoodian},
year = {2026},
journal = {Iranian Journal of Allergy, Asthma and Immunology},
doi = {10.18502/ijaai.v25is11.22488},
url = {https://doi.org/10.18502/ijaai.v25is11.22488}
}RIS
TY - JOUR TI - Clinical and Inflammatory Benefits of Nebulized Furosemide with Salbutamol–ipratropium in COPD Exacerbations: A Randomized Controlled Trial AU - Mahdi Behi AU - Babak Gholamine AU - Mohammad Reza Masjedi AU - Alireza Eslaminejad AU - Esmaeil Idani AU - Mohsen Sadeghi AU - Akram Qanavati AU - Sayed Mehran Marashian AU - Esmaeil Mortaz AU - Atefeh Abedini AU - Mihan Pourabdollah AU - Bita Pakshad AU - Saeid Mahmoodian PY - 2026 JO - Iranian Journal of Allergy, Asthma and Immunology DO - 10.18502/ijaai.v25is11.22488 UR - https://doi.org/10.18502/ijaai.v25is11.22488 ER -
APA
Behi, M., Gholamine, B., Masjedi, M. R., Eslaminejad, A., Idani, E., Sadeghi, M., Qanavati, A., Marashian, S. M., Mortaz, E., Abedini, A., Pourabdollah, M., Pakshad, B., & Mahmoodian, S. (2026). Clinical and Inflammatory Benefits of Nebulized Furosemide with Salbutamol–ipratropium in COPD Exacerbations: A Randomized Controlled Trial. Iranian Journal of Allergy, Asthma and Immunology. https://doi.org/10.18502/ijaai.v25is11.22488
Source records
- crossref · retrieved 2026-09-26T05:33:36.266Z